WillItSurvive
Food tech and alternative protein · United States

Finless Foods

finlessfoods.com ↗

Cell-cultured seafood startup racing to bring lab-grown bluefin tuna to market.

Little protection left
Assessed 25 July 2026 · Evidence as of 25 July 2026
Not much stands between this business and its pressures.
On the recordSince 25 July 2026 · Checkable from 2026 (raise); 2027 (FDA) · Every call on the record Checkpoint: Republic Reg CF crowdfunding round outcome, plus FDA review decision on cultivated bluefin tuna
The call

Finless Foods is trying to reach FDA clearance and revenue before its cash runs out, while better-funded rivals move toward the same bluefin tuna market first.

Finless Foods grows bluefin tuna in tanks instead of catching it from the ocean. The company got FDA approval to sell it, but hasn't shipped any yet and won't be able to until 2027. Two better-funded rivals, BlueNalu and Wildtype, are clearing their own lab-grown seafood first or already selling it, which means they could capture customers before Finless Foods even launches. The one thing that could save the company is if its crowdfunding round raises enough cash to survive until its tuna actually ships, but even then it will be fighting an uphill battle against competitors with much more money and a head start in the market.

Why
01
AI pressure: None apparent. This is a biology and regulatory race, not an AI-exposed business; no AI product threatens its market. Could AI do the core job? Unlikely.
02
Bigger players: BlueNalu and Wildtype. BlueNalu says bluefin FDA clearance is 'quite imminent' and has raised $129M; Wildtype already sells cultivated coho salmon. Could a giant copy it? Probably.
03
What protects it. A cell line for cultivated bluefin tuna that a buyer like Hanwha or a Japanese seafood major might still want, even if the company folds.
What would change this call
Whether BlueNalu receives FDA clearance for cultivated bluefin tuna before Finless in 2026-2027. Shows if Finless loses its first-mover claim on its core product.
Outcome of Finless's Republic Reg CF round (target $75K-$1.24M) by mid-2026. Indicates whether Finless can secure near-term operating cash.
Whether Finless announces a new institutional Series C or a strategic acquisition within 12 months. Shows if investors still believe in Finless's bluefin tuna bet.
Key numbers
  • ~$48M total raised since 2017 (2026-07-24)
  • Reg CF raise at ~$5M valuation, target $75K-$1.24M (2026-04)
  • ~8.9 months of runway, ~$32.9K monthly burn (2026-02)
Named risks
  • Only ~8.9 months of cash runway reported as of February 2026 with near-zero revenue. Severity: high
  • Core cultivated bluefin tuna product still awaits FDA clearance, not expected until 2027. Severity: high
  • Direct rivals BlueNalu and Wildtype may clear FDA review or reach market first. Severity: high
  • State-level cultivated meat bans in Texas, Mississippi, Alabama, and Florida threaten market access. Severity: medium
  • Sector-wide attrition warning of 70-90% company failure within a year in cultivated seafood. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
BlueNalulosing toBlueNalu, ~$129M raised, said FDA bluefin clearance was quite imminent as of 2026-03
Wildtypelosing toWildtype got FDA clearance and began selling cultivated salmon on 2025-05-28, ahead of Finless
UPSIDE Foodslosing toUPSIDE Foods, reported $580M+ raised, got FDA/USDA clearance Nov 2022 and sold commercially July 2023
Questions people ask
Is Finless Foods profitable in 2026?
No. Finless Foods reported FY2025 revenue of only $0 to $4,500 and a monthly burn of roughly $32,900, leaving about 8.9 months of runway as of February 2026, per its own Republic/KingsCrowd crowdfunding disclosures dated 2026-04-30.
Is Finless Foods running out of money?
Yes, signs point that way. As of February 2026 Finless Foods had roughly 8.9 months of runway and was raising a small Reg CF round on Republic at a $5 million valuation, down sharply from about $48 million raised since 2017, per KingsCrowd, 2026-04-30.
Who is Finless Foods' biggest competitor?
BlueNalu and Wildtype. BlueNalu, which has raised about $129 million, said in March 2026 that FDA clearance for its cultivated bluefin tuna was quite imminent, while Wildtype already got FDA clearance for cultivated salmon and began selling it on May 28, 2025.
Could AI replace Finless Foods' work?
Unlikely. Finless Foods' core activity is wet-lab cell-line development and FDA regulatory science for cultivated bluefin tuna, which is physical biology and regulatory process work, not information processing that current AI systems can substitute for directly.
Who owns Finless Foods?
Finless Foods is privately held, backed by Draper Associates from a 2018 seed round and by a $34 million Series B closed in March 2022 led by Hanwha Solutions with At One Ventures and Blue Horizon, per SeafoodSource, 2026-07-20 (originally reported March 2022).
When will Finless Foods' cultivated tuna actually launch?
Not before 2027. Finless Foods' own investor materials state FDA review of its cultivated bluefin tuna sashimi is expected to conclude only in 2027, while rival BlueNalu said in March 2026 its own bluefin clearance was quite imminent.
Timeline
  • 2026-04Opened Reg CF crowdfunding round on Republic at $5M valuation, targeting $75K-$1.24M
  • 2026-03Competitor BlueNalu says FDA clearance for cultivated bluefin tuna is quite imminent
  • 2026-02Reported ~8.9 months cash runway and ~$32.9K monthly burn
  • 2026-01Federal judge denies Texas motion to dismiss cultivated meat ban lawsuit
  • 2025-09-01Texas SB 261 cultivated meat ban takes effect (expires 2027-09-01)
  • 2025-05-28Competitor Wildtype gets FDA clearance for cultivated salmon, starts sales
  • 2025-01Brandon Chen becomes CEO, succeeding co-founder Mike Selden
  • 2024-02Further layoffs; company terminates D.C. lobbying firm
  • 2023-04Company conducts layoffs
  • 2022-03Closes $34M Series B led by Hanwha Solutions
Revision history
25 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Aspire Food GroupAgEagle Aerial SystemsBeyond Meat
More in Food tech and alternative protein →
Sources